Merck explores vaccine market in China; Elanco to distribute new pig vaccine in the EU; TVAX pulls in $2M to develop cancer drugs;

> Merck ($MRK) Animal Health and China Animal Husbandry Industry have established a partnership to explore animal vaccine opportunities in China. Release

> Prevtec Microbia has won European approval for its pig vaccine Coliprotec F4, which will be distributed in the EU by Eli Lilly's ($LLY) Elanco animal health unit. Release

> Kansas-based startup TVAX Animal Health, which is developing an immunotherapy-based cancer treatment for the veterinary market, raised an additional $2 million in funding, bringing its total financing to $12 million. Article

> France agricultural group InVivo pulled in €215 million ($235.3 million), led by private equity firm Eurazeo, and plans to use the funds to double the size of its animal health and nutrition division. Article

> Zoetis ($ZTS) awarded $974,000 in scholarships to 487 second- and third-year veterinary students in the U.S. and Caribbean. Release

> Denis Brinicombe Group in the U.K. has been named the first international licensee of Integrated Animal Health's dairy feed inclusion technology, Feed Mate, in a four-year deal. Release

> The FDA announced a new strategy for creating standards for animal food ingredients, which will include proposing rules for the use of additives. Release

Suggested Articles

Pfizer spinoff Zoetis met Q2 expectations and brightened its full-year forecast, but it's looking to M&A to drive further growth.

Fresenius’ new CEO has pulled off a dealmaking double play, committing more than $5.4 billion to expand its reach in both sterile generics and in biosimilars.

Bayer’s pharma products have been growing lickety-split, and its 2016 numbers show just how—and how much. But with the big Monsanto merger top of mind at Bayer…